Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
Holding INSP?
Track your performance easily
Earnings Data
Report Date
Feb 11, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.72Last Year’s EPS
$0.49Same Quarter Last Year
Moderate Buy
Based on 15 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 04, 2024
|% Change Since: -2.56%
|Next Earnings Date:Feb 11, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong positive outlook with significant revenue growth, profitability, and expansion, albeit with some minor challenges related to external factors like hurricanes and IV solution shortages impacting the fourth quarter.Company Guidance
In the third quarter of 2024, Inspire Medical Systems surpassed 85,000 patients treated with Inspire therapy, reporting a strong financial performance with revenue of $203.2 million, reflecting a 33% increase from the previous year. The company expanded its network with 66 new implanting centers in the U.S. and 13 new U.S. sales territories, bringing the total to 1,371 active centers and 323 sales territories. International revenue grew by 27% to $7.4 million, with significant contributions from Germany, Switzerland, the Netherlands, and Belgium. Despite challenges from hurricanes and an IV solution shortage, the company raised its full-year revenue guidance to $793-$798 million and earnings per share guidance to $1.20-$1.40. Operational highlights include a gross margin of 84.1% and a net income of $18.5 million, or $0.60 per share, up from a net loss in the prior year. The company is preparing for a soft launch of the Inspire V neurostimulation system and continues to focus on enhancing patient outcomes and market access.Revenue Growth and Record Earnings
In the third quarter, Inspire Medical Systems generated revenue of $203.2 million, representing a 33% increase compared to the third quarter of 2023. Net income for the third quarter was $18.5 million, compared to a net loss of $8.5 million in the prior year period.
Expansion and Market Penetration
The company expanded into 66 new implanting centers in the United States and 13 new U.S. sales territories, bringing the total to 1,371 active U.S. centers and 323 U.S. sales territories.
Strong International Performance
Revenue outside the U.S. increased 27% year-over-year to $7.4 million, with notable strength in Germany, Switzerland, the Netherlands, and Belgium. Reimbursed procedures have begun in France.
Updated Revenue Guidance
Inspire Medical Systems increased its 2024 revenue guidance to $793 million to $798 million, representing 27% to 28% growth over 2023 revenue.
Gross Margin and Cash Flow
Gross margin in the quarter was 84.1%. The company generated $52 million in operating cash flow during the third quarter, increasing total cash and investment balances to $524 million.
Peer-Reviewed Publication
A recent peer review publication in the Journal of Clinical Sleep Medicine reviewed data from over 20,000 patients, showing continued improvement in patient safety and significant outcomes.
---
INSP Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
INSP Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 04, 2024 | $192.71 | $199.00 | +3.26% |
| Aug 06, 2024 | $147.01 | $188.38 | +28.14% |
| May 07, 2024 | $245.63 | $163.41 | -33.47% |
| Feb 06, 2024 | $226.00 | $202.16 | -10.55% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Inspire Medical Systems (INSP) report earnings?
Inspire Medical Systems (INSP) is schdueled to report earning on Feb 11, 2025, TBA Not Confirmed.
What is Inspire Medical Systems (INSP) earnings time?
Inspire Medical Systems (INSP) earnings time is at Feb 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is INSP EPS forecast?
INSP EPS forecast for the fiscal quarter 2024 (Q4) is $0.72.
---